Volume 8 Issue 163
Published - 14:00 UTC 08:00 EST 12-Jun-2006 
Next Update - 14:00 UTC 08:00 EST 13-Jun-2006

Editor: Susan K. Boyer, RN
Vidyya.
All rights reserved.

HONcode accreditation seal. We subscribe to the HONcode principles.
Verify here
.

  

 


Joslin discovers signs of residual islet cell function in people with long-term type 1 diabetes

Scientists at Joslin Diabetes Center have discovered that a surprisingly high percentage of people with type 1 diabetes (insulin-dependent) who have had the disease for 50 years or longer (The Joslin Medalists) may still have residual functioning, insulin-producing islet cells and/or islet cell antibodies. more  

Hodgkin disease type is a major determinant of prognosis

Regional differences in the survival of Hodgkin disease (HD) can be partially explained by the type of HD, according to a new population level study. Published in the July 15, 2006 issue of Cancer, a peer-reviewed journal of the American Cancer Society, the study reveals that while nodular sclerosis was much more common in the United States than Europe, there was significant HD variability across Europe. more

Encouraging results for folic acid as a cancer prevention drug

Folic acid supplements may prevent cancer progression and promote regression of disease, according to a new study. Published in the July 15, 2006 issue of Cancer, the small study found that 31 of 43 patients with the precancerous laryngeal lesion called leucoplakia demonstrated 50 percent or greater reduction in the lesion size after six months of taking folate supplements. In 12 of 31 responders, there was no evidence of the original lesion. Folate levels in the patients' blood also increased significantly from baseline while homocysteine levels decreased significantly. more  

Lack of key enzyme associated with development of rare tumor

Researchers at the National Institutes of Health have discovered that a rare tumor of the adrenal glands appears to result from a genetic deficiency of an important enzyme. The enzyme is one of a class of enzymes involved in halting a cell's response to hormones and appears to stop cells from dividing. more

More than one-third of disaster victims may suffer from stress disorder 

In the year after a hurricane, tornado, terrorist attack or other natural or man-made disaster, 30 to 40 percent of adults who were directly affected may suffer from post-traumatic stress disorder, according to a University of Michigan researcher. more

Peruvian plant points the way to wound-healing discovery  

Research on a plant renowned in traditional Peruvian medicine has enabled chemists to discover that an inexpensive, commercially available material has a remarkable ability to speed the healing of wounds. Chronic, nonhealing wounds are a multi-billion-dollar health care problem. An estimated 5 million people in the United States suffer from wounds that do not heal normally. more

Backs to the future

Tell an old Aymara speaker to "face the past!" and you just might get a blank stare in return because he or she already does. New analysis of the language and gesture of South America's indigenous Aymara people indicates a reverse concept of time. more

 

Is your past ahead of you or behind you?